Protocol INCB 39110-106

Admin 0 Comments

Protocol INCB 39110-106: A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of INCB Combinations in Advanced Solid Tumors.

Sponsor: Incyte Corporation

Status: Enrolling

https://clinicaltrials.gov/ct2/show/NCT02559492

 

Leave a Reply

Your email address will not be published. Required fields are marked *